Get all your news in one place.

100's of premium titles.
One app.

Start reading

Get all your news in one place.

100's of premium titles. One news app.

Start reading

The Latest Breaking News from Solventum

Solventum Earnings Preview: What to Expect

Solventum will release its first-quarter earnings next month, and analysts anticipate a marginal bottom-line growth.

Barchart

Solventum Stock: Is Wall Street Bullish or Bearish?

Solventum has lagged behind the broader market over the past year, and analysts remain somewhat optimistic about the stock’s prospects.

Barchart

What You Need To Know Ahead of Solventum Earnings Release

Solventum is expected to release its fiscal fourth-quarter earnings soon, and analysts project a modest earnings increase.

Barchart

From analysis to the latest developments in health,
read the most diverse news in one place.

Protect your agentic AI before you wreck your agentic AI

On the nuances of agentic AI-driven change management during the 2026 Fortune Brainstorm Tech dinner during CES in Las Vegas.

Fortune

Is Solventum Stock Outperforming the Nasdaq?

Solventum has delivered stronger performance than the Nasdaq Composite over the past year, reinforcing analysts’ moderate optimism regarding the stock’s forward outlook.

Barchart

Up Over 20% in 2025, These 3 Stocks Are Boosting Buyback Capacity

Check out these three stocks that are up more than 20% in 2025 and just increased their buyback capacity. One stock experiencing strong growth stands out.

MarketBeat

Solventum Stock: Analyst Estimates & Ratings

Solventum has underperformed the broader market over the past year, but analysts are cautiously optimistic about the stock’s prospects.

Barchart

Read news from The Economist, FT, and more,
with one subscription

What to Expect From Solventum's Next Quarterly Earnings Report

Solventum will release its third-quarter earnings next month, and analysts anticipate a double-digit bottom-line growth.

Barchart

Do Wall Street Analysts Like Solventum Stock?

Although Solventum has outperformed the broader market over the past year, Wall Street analysts maintain a cautiously optimistic outlook on the stock’s prospects.

Barchart

What to Expect From Solventum's Q2 2025 Earnings Report

Solventum will release its second-quarter earnings next month, and analysts anticipate a single-digit profit dip.

Barchart

How Is Solventum's Stock Performance Compared to Other Health Care Equipment Stocks?

Solventum has outperformed relative to its healthcare equipment peers over the past year, but Wall Street analysts maintain a skeptical view on the stock’s outlook.

Barchart

Solventum Stock Outlook: Is Wall Street Bullish or Bearish?

Solventum has outperformed the broader market over the past year, yet analysts remain cautious about the stock’s prospects.

Barchart

Here's What to Expect From Solventum’s Next Earnings Report

Solventum is expected to unveil its first quarter results in the upcoming month, and analysts predict its bottom line to suffer in double digits.

Barchart

Solventum Stock: Is SOLV Outperforming the Healthcare Sector?

Despite outpacing the healthcare sector over the past year, analysts remain cautious about the stock’s prospects.

Barchart

Get all your
news in one place.

100's of premium titles.
One news app.

Barchart

Are Wall Street Analysts Predicting Solventum Stock Will Climb or Sink?

Although Solventum has outperformed the broader market over the past year, Wall Street analysts remain cautious about the stock's growth potential.

Barchart

Earnings Preview: What to Expect from Solventum’s Report

Recently spun-off healthcare major Solventum is expected to announce its fourth-quarter results in the upcoming month and analysts predict an EPS of $1.31.

Barchart

Is Solventum Stock Underperforming the Dow?

Solventum has underperformed compared to the Dow index over the past three months, though analysts remain cautious about the stock’s growth prospects.

Benzinga

A Peek at Cooper Companies's Future Earnings

Cooper Companies (NYSE:COO) is gearing up to announce its quarterly earnings on Thursday, 2024-12-05. Here's a quick overview of what investors should know before the release.

Get all your
news in one place.

100's of premium titles.
One news app.

Benzinga

5 Analysts Have This To Say About Solventum

In the preceding three months, 5 analysts have released ratings for Solventum (NYSE:SOLV), presenting a wide array of perspectives from bullish to bearish.

Barchart

Is Wall Street Bullish or Bearish on Solventum Stock?

Due to Solventum’s underperformance relative to the broader S&P 500 Index over the past six months, Wall Street analysts remain cautious about the stock’s prospects.

Barchart

Solventum's Quarterly Earnings Preview: What You Need to Know

Solventum is scheduled to report its third-quarter results next month.

Barchart

Is Solventum Stock Outperforming the Nasdaq?

Solventum outperformed the broader market recently, but Wall Street analysts remain cautious about the stock’s prospects.

Barchart

Are Wall Street Analysts Bullish on Solventum Stock?

Solventum has underperformed the broader market over the past three months, and Wall Street analysts are cautious about the stock's potential.

Barchart

Solventum’s Q2 2024 Earnings: What to Expect

Solventum is gearing up to unveil its second-quarter earnings next month. Here’s what analysts are predicting.

Barchart

What to Expect From 3M’s Q2 2024 Earnings Report

3M is expected to release its second-quarter earnings later this month, and analysts project a double-digit profit dip.

1 2

Organisations

From analysis to the latest developments in health,
read the most diverse news in one place.

Topics

Health Care

3,224 stories

Read news from The Economist, FT, and more,
with one subscription

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.